Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 134 results.
User Information
Export Records
  1. 1.   Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE
  2. Tanwar, Shalini; Oguz,Cihan; Metidji, Amina; Dahlstrom, Eric; Barbian, Kent; Kanakabandi, Kishore; Sykora, Lydia; Shevach, Ethan M
  3. Journal of autoimmunity. 2020, DEC; 115: 102525.
  1. 2.   Tissue specific production of MicroRNA-155 inhibits melanocortin 5 receptor dependent suppressor macrophages to promote experimental autoimmune uveitis
  2. Muhammad, Fauziyya; Trivett,Anna; Wang, Dawei; Lee, Darren J
  3. European journal of immunology. 2019, Nov; 49(11): 2074-2082.
  1. 3.   Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis
  2. Yang, Yuan; Yang, Howard H.; Hu, Ying; Watson, Peter H.; Liu, Huaitian; Geiger, Thomas R.; Anver, Miriam R.; Haines, Diana; Martin, Philip; Green, Jeffrey E.; Lee, Maxwell P.; Hunter, Kent W.; Wakefield, Lalage M.
  3. Oncotarget. 2017, May 9; 8(19): 30621-30643.
  1. 4.   Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers
  2. Howard, James J.; Sturge, Carolyn R.; Moustafa, Dina A.; Daly, Seth M.; Batty, Kimberly; Felder, Christina F.; Zamora, Danniel; Yabe-Gill, Marium; Labandeira-Rey, Maria; Bailey, Stacey M.; Wong, Michael; Goldberg, Joanna B.; Geller, Bruce L.; Greenberg, David E.
  3. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017, Apr; 61(4):
  1. 5.   Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis
  2. Yang, Yuan; Yang, Howard H; Hu, Ying; Watson, Peter H; Liu, Huaitian; Geiger, Thomas R; Anver, Miriam R; Haines, Diana; Martin, Philip; Green, Jeffrey E; Lee, Maxwell P; Hunter, Kent W; Wakefield, Lalage M
  3. Oncotarget. 2017, Feb 25;
  1. 6.   Configuration-dependent Presentation of Multivalent IL-15:IL-15Ralpha Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity
  2. Hong, E.; Usiskin, I. M.; Bergamaschi, C.; Hanlon, D. J.; Edelson, R. L.; Justesen, S.; Pavlakis, G. N.; Flavell, R. A.; Fahmy, T. M.
  3. The Journal of biological chemistry. 2016, 22-Apr; 291(17): 8931-50.
  1. 7.   Polymorphic Triple beta-Sheet Structures Contribute to Amide Hydrogen/Deuterium (H/D) Exchange Protection in the Alzheimer Amyloid beta 42 Peptide
  2. Ma, B. Y.; Nussinov, R.
  3. Journal of Biological Chemistry. 2011, Sep; 286(39): 34244-34253.
  1. 8.   High-Mobility Group Box-1 Mediates Toll-Like Receptor 4-Dependent Angiogenesis
  2. Lin, Q.; Yang, X. P.; Fang, D.; Ren, X. R.; Zhou, H. Y.; Fang, J. Z.; Liu, X. L.; Zhou, S. Y.; Wen, F.; Yao, X. H.; Wang, J. M.; Su, S. B.
  3. Arteriosclerosis Thrombosis and Vascular Biology. 2011, May; 31(5): 1024-U174.
  1. 9.   Molecular-Level Examination of Cu2+ Binding Structure for Amyloid Fibrils of 40-Residue Alzheimer's beta by Solid-State NMR Spectroscopy
  2. Parthasarathy, S.; Long, F.; Miller, Y.; Xiao, Y. L.; McElheny, D.; Thurber, K.; Ma, B. Y.; Nussinov, R.; Ishii, Y.
  3. Journal of the American Chemical Society. 2011, Mar; 133(10): 3390-3400.
  1. 10.   Cloning of guinea pig IL-4: Reduced IL-4 mRNA after vaccination or Mycobacterium tuberculosis infection
  2. Jeevan, A.; Yoshimura, T.; Ly, L. H.; Dirisala, V. R.; McMurray, D. N.
  3. Tuberculosis. 2011, Jan; 91(1): 47-56.
  1. 11.   Polymorphic C-terminal beta-Sheet Interactions Determine the Formation of Fibril or Amyloid beta-derived Diffusible Ligand-like Globulomer for the Alzheimer A beta 42 Dodecamer
  2. Ma, B. Y.; Nussinov, R.
  3. Journal of Biological Chemistry. 2010, Nov; 285(47): 37102-37110.
  1. 12.   NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
  2. Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P. L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I. J.; Kitani, A.; Strober, W.
  3. Journal of Clinical Investigation. 2010, May; 120(5): 1645-1662.
  1. 13.   Genetically engineered mouse models in cancer research
  2. Walrath, J. C.; Hawes, J. J.; Van Dyke, T.; Reilly, K. M.
  3. Advances in cancer research. 2010, Apr 16; 106: 113-64.
  1. 14.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 15.   A suppressive oligodeoxynucleotide inhibits ocular inflammation
  2. Fujimoto, C.; Klinman, D. M.; Shi, G.; Yin, H.; Vistica, B. P.; Lovaas, J. D.; Wawrousek, E. F.; Igarashi, T.; Chan, C. C.; Gery, I.
  3. Clinical and Experimental Immunology. 2009 156(3): 528-534.
  1. 16.   Noninvasive Monitoring of a Murine Model of Metastatic Pheochromocytoma: A Comparison of Contrast-Enhanced MicroCT and Nonenhanced MRI
  2. Martiniova, L.; Kotys, M. S.; Thomasson, D.; Schimel, D.; Lai, E. W.; Bernardo, M.; Merino, M. J.; Powers, J. F.; Ruzicka, J.; Kvetnansky, R.; Choyke, P. L.; Pacak, K.
  3. Journal of Magnetic Resonance Imaging. 2009 29(3): 685-691.
  1. 17.   Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
  2. Ahlenstiel, G.; Martin, M. P.; Gao, X. J.; Carrington, M.; Rehermann, B.
  3. Journal of Clinical Investigation. 2008 118(3): 1017-1026.
  1. 18.   Application of a global proteomic approach to archival precursor lesions: Upregulation of DMBT-1 and TG2 in pancreatic cancer precursors
  2. Cheung, W. L.; Krizman, D. B.; Alvarez, H.; Hood, B. L.; Darfler, M. M.; Veenstra, T. D.; Mollenhauer, J.; Habbe, N.; Feldman, G.; Maita, A.
  3. Laboratory Investigation. 2008 88: 524-.
  1. 19.   Epizootiology and management of feline leukemia virus in the Florida puma
  2. Cunningham, M. W.; Brown, M. A.; Shindle, D. B.; Terrell, S. P.; Hayes, K. A.; Ferree, B. C.; McBride, R. T.; Blankenship, E. L.; Jansen, D.; Citino, S. B.; Roelke, M. E.; Kiltie, R. A.; Troyer, J. L.; O'Brien, S. J.
  3. Journal of Wildlife Diseases. 2008 44(3): 537-552.
  1. 20.   Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
  2. Dobrikova, E. Y.; Broadt, T.; Poiley-Nelson, J.; Yang, X. Y.; Soman, G.; Giardina, S.; Harris, R.; Gromeier, M.
  3. Molecular Therapy. 2008 16(11): 1865-1872.
  1. 21.   Elevated hydrostatic pressure promotes protein recovery from formalin-fixed, paraffin-embedded tissue surrogates
  2. Fowler, C. B.; Cunningham, R. E.; Waybright, T. J.; Blonder, J.; Veenstra, T. D.; Mason, J. T.; O'Leary, T. J.
  3. Laboratory Investigation. 2008 88(Supp 1s): 365A-365A.
  1. 22.   Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells
  2. Gerosa, F.; Baldani-Guerra, B.; Lyakh, L. A.; Batoni, G.; Esin, S.; Winkler-Pickett, R. T.; Consolaro, M. R.; De Marchi, M.; Giachino, D.; Robbiano, A.; Astegiano, M.; Sambataro, A.; Kastelein, R. A.; Carra, G.; Trinchieri, G.
  3. Journal of Experimental Medicine. 2008 205(6): 1447-1461.
  1. 23.   DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation
  2. Guo, Z. J.; Tsai, M. H.; Shiao, Y. H.; Chen, L. H.; Wei, M. L.; Lv, X.; Gius, D.; Little, J. B.; Mitchell, J. B.; Chuang, E. Y.
  3. Journal of Biomedical Science. 2008 15(2): 163-168.
  1. 24.   Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy
  2. Hai, M.; Adler, R.; Bauer, T. R.; Tuschong, L. M.; Gu, Y. C.; Wu, X.; Hickstein, D. D.
  3. Gene Therapy. 2008 15(14): 1067-1071.
  1. 25.   Detecting AIDS restriction genes: From candidate genes to genome-wide association discovery
  2. Hutcheson, H. B.; Lautenberger, J. A.; Nelson, G. W.; Pontius, J. U.; Kessing, B. D.; Winkler, C. A.; Smith, M. W.; Johnson, R.; Stephens, R.; Phair, J.; Goedert, J. J.; Donfield, S.; O'Brien, S. J.
  3. Vaccine. 2008 26(24): 2951-2965.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel